- Inhibítory komplementu ekulizumab a ravulizumab v liečbe generalizova…
Number of the records: 1  

Inhibítory komplementu ekulizumab a ravulizumab v liečbe generalizovanej myasténie gravis (gMG)

  1. Inhibítory komplementu ekulizumab a ravulizumab v liečbe generalizovanej myasténie gravis (gMG) = Complement inhibitors eculizumab and revulizumab in the treatment of generalized myasthenia gravis (gMG) / Ivan Martinka. Neurológia pre prax Roč. 25, č. 5 (2024), s. 329-332 a 334
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.